Clinical trial
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
NCT02427191 is registered in ClinicalTrials.gov with MiMedx Group, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
- Lead sponsor
- MiMedx Group, Inc.
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 31, 2015
- Completion date
- August 31, 2018
- Enrollment
- 147 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.